Regentis Biomaterials Ltd. RGNT
1.27 USD -0.06 (-4.51%)
At closeNov 12, 2026, 6:25 AM EST
1.22 -0.05 -4.13%
Pre-market · Nov 12, 6:25 AM ET
1.23 Day range 1.33
1.16 52-week range 15.50
- YTD
- -81.16%
- 1 year
- -83.07%
RGNT revenue history
Revenue is income from the company’s ordinary business activities.
0 USD
FY 2025 · Period ended
Coverage: incomplete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 0 | 0 | Not meaningful |
| FY 2024 | 2024-12-31 | 0 | 0 | Not meaningful |
| FY 2023 | 2023-12-31 | 0 | Not available | Not available |
| FY 2001 | 2001-12-31 | 64,025,432 | -883,307 | -1.36% |
| FY 2000 | 2000-12-31 | 64,908,739 | 10,819,724 | 20.00% |
| FY 1999 | 1999-12-31 | 54,089,015 | 23,669,820 | 77.81% |
| FY 1998 | 1998-12-31 | 30,419,195 | 16,460,913 | 117.93% |
| FY 1997 | 1997-12-31 | 13,958,282 | 698,033 | 5.26% |
| FY 1996 | 1996-12-31 | 13,260,249 | 3,121,440 | 30.79% |
| FY 1995 | 1995-12-31 | 10,138,809 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-03-06T15:18:25.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.